Related Articles
Prognostic analysis of triple-negative breast cancer patients treated with adjuvant chemotherapy of fluorouracil, epirubicin and cyclophosphamide
Severe cytopenia during adjuvant chemotherapy for early breast cancer in a patient with idiopathic CD4+ lymphocytopenia
Effect of PREDICT on chemotherapy/trastuzumab recommendations in HER2‑positive patients with early‑stage breast cancer
Clinicopathological characteristics, adjuvant chemotherapy decision and disease outcome in patients with breast cancer with a 21‑gene recurrence score of 26‑30
Correlation analysis between ultrasonography and mammography with other risk factors related to breast cancer